Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics, Inc.

Akrevia Therapeutics is discovering and developing the next generation of cancer immunotherapies, offering the promise of safer, more efficacious therapeutics
Raised
$30M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$30,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
$30,000,000 Venture capital (Series A)
FinSMEs , PE HUB , MedCity News , +1

Akrevia Therapeutics Raises $30M in Series A Financing

Funding Health